Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Sponsor
US Department of Veterans Affairs (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00018343
Collaborator
(none)
1
35
Study Details
Study Description
Brief Summary
This study is designed to evaluate the potential beneficial effects of estrogen on cognitive function of women with Alzheimer's Disease.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 2 |
Study Design
Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double
Primary Purpose:
Treatment
Official Title:
Alzheimer's Disease and Aging: Therapeutic Potential of Estrogen
Study Start Date
:
Apr 1, 1998
Study Completion Date
:
Mar 1, 2001
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
50 Years
to 90 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
-
Post menopausal women with alzheimer's disease
-
free of any major medical or neurological disease,
-
medically safe to be treated with estrogen.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | VA Puget Sound Health Care System | Lakewood | Washington | United States | 98493-5000 |
Sponsors and Collaborators
- US Department of Veterans Affairs
Investigators
- : Suzanne Craft, Ph.D,
- : Laura Baker, Ph.D,
- : Murray Raskind, M.D.,
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00018343
Other Study ID Numbers:
- AGCG-007-97F
First Posted:
Jul 5, 2001
Last Update Posted:
Jan 21, 2009
Last Verified:
Dec 1, 2004